Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Pain and Symptom Management|August 24, 2025
Perceived Gaps between Wishes and Practice in End-of-life Sedation for Psycho-existential SufferingSayaka Maeda, Tatsuya Morita, Kengo Imai, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 24, 2012
Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering propertyHideyuki Hyogo, Sho-ichi Yamagishi, Sayaka Maeda, et al.
Journal of Natural Products|March 4, 2024
Total Synthesis of a TNBC-Selective Cytotoxic Bromo Nor-eremophilane, PC-A, and Its Preliminary Structure-Activity RelationshipsSayaka Maeda, Wakana Nakayama, Yohei Saito, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 20, 2012
Increased insulinogenic index is an independent determinant of nonalcoholic fatty liver disease activity score in patients with normal glucose toleranceHideyuki Hyogo, Sho-ichi Yamagishi, Sayaka Maeda, et al.
Pediatric Hematology and Oncology|May 8, 2020
Continuous deep sedation at the end of life in children with cancer: experience at a single center in JapanSayaka Maeda, Itaru Kato, Katsutsugu Umeda, et al.
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|January 30, 2008
Molecular cloning of ecdysone 20-hydroxylase and expression pattern of the enzyme during embryonic development of silkworm Bombyx moriSayaka Maeda, Asuka Nakashima, Ryouichi Yamada, et al.
Oxidative Medicine and Cellular Longevity|December 15, 2010
Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs)Tsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Pageof 5